M&S M&Ss Nutrient Dense range has been designed in consultation with the British Nutrition Foundation and is said to be ideal for those eating less due to weight-loss medication, lifestyle or age
however, shared decision-making between the primary care physician and patient is important for improving patient outcomes
They are accelerating trials for semaglutide in treating MASH (liver disease) and chronic kidney disease, markets where they hope to maintain higher pricing power due to the critical nature of the conditions
GLP-1 therapy requires ongoing safety monitoring for pancreatitis symptoms, severe nausea, and other adverse effects
[cited 2026 Feb 11];597611
December 22nd, 2025: JPML Assigns GLP-1 Vision Loss Cases to Judge Handling Stomach Injury MDL The Judicial Panel on Multidistrict Litigation has directed all federal lawsuits alleging vision loss linked to Ozempic, Wegovy, and other GLP-1 medications to be centralized in the Eastern District of Pennsylvania